In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?
PICO question In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the Canine Atopic Dermatitis Lesion Index score (or some other recognised scoring system)? Clinical bottom line Category of research question Treatment The number and type of...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
RCVS Knowledge
2022-06-01
|
| Series: | Veterinary Evidence |
| Subjects: | |
| Online Access: | https://veterinaryevidence.org/index.php/ve/article/view/569 |